Q3 Fiscal 2015 | Q3 Fiscal 2014 | Year-Over-Year Change | Q2 Fiscal 2015 | Sequential Change | |||||
Revenues 1 | $5.8B | $6.8B | (14%) | $6.9B | (15%) | ||||
Operating income 1 | $1.2B | $2.1B | (40%) | $1.3B | (8%) | ||||
Net income 2 | $1.2B | $2.2B | (47%) | $1.1B | +12% | ||||
Diluted earnings per share 2 | $0.73 | $1.31 | (44%) | $0.63 | +16% | ||||
Operating cash flow | $2.1B | $2.7B | (21%) | ($0.7B) | N/M |
Q3 Fiscal 2015 | Q3 Fiscal 2014 | Year-Over-Year Change | Q2 Fiscal 2015 | Sequential Change | |||||
Revenues | $5.8B | $6.8B | (14%) | $6.9B | (15%) | ||||
Operating income | $1.7B | $2.4B | (30%) | $2.7B | (37%) | ||||
Net income | $1.6B | $2.5B | (35%) | $2.3B | (31%) | ||||
Diluted earnings per share | $0.99 | $1.44 | (31%) | $1.40 | (29%) |
• | The third quarter of fiscal 2015 GAAP results included: |
◦ | $142 million of charges, or $0.08 per share, that resulted from an impairment of goodwill and long-lived assets related to one of our display businesses. |
• | The second quarter of fiscal 2015 GAAP results included: |
◦ | $975 million charge, or $0.58 per share, related to the resolution reached with the China National Development and Reform Commission (NDRC) regarding its investigation of us under China’s Anti-Monopoly Law; and |
◦ | Operating cash flow also was impacted by the prepayment of $950 million to secure long-term capacity commitments at a supplier of our integrated circuit products. |
• | The third quarter of fiscal 2014 Non-GAAP and GAAP results included: |
◦ | $208 million of income, or $0.12 per share, of which $184 million was recorded in other income, due to the reversal of accruals related to our litigation with ParkerVision; and |
◦ | $164 million of charges, or $0.08 per share, that resulted from an impairment of goodwill and long-lived assets related to one of our display businesses. |
Q3 Fiscal 2015 | Q3 Fiscal 2014 | Year-Over-Year Change (1) | Q2 Fiscal 2015 | Sequential Change (1) | |||||
MSMTM chip shipments | 225M | 225M | —% | 233M | (3%) | ||||
Total reported device sales (2) | $60.4B | $58.1B | +4% | $75.8B | (20%) | ||||
Est. reported 3G/4G device shipments (approx.) (2) | 289M - 293M | 250M - 254M | +15% | 384M - 388M | (25%) | ||||
Est. reported 3G/4G average selling price (approx.) (2) | $205 - $211 | $228 - $234 | (10%) | $193 - $199 | +6% |
(1) | The midpoints of the estimated ranges are used for comparison purposes only and do not indicate a higher degree of confidence in the midpoints. |
(2) | The third quarter of fiscal 2014 and 2015 are based on sales by our licensees in the March quarter as reported to us in the June quarter, and the second quarter of fiscal 2015 is based on sales by our licensees in the December quarter as reported to us in the March quarter. |
• | Increased concentration within the premium tier causing reduced demand for certain OEM devices that include our chipset; |
• | Lower demand for our premium-tier chipsets from a vertical customer; and |
• | Lower sell through in China of certain handset models using our premium-tier chipsets. |
• | We expect global 3G/4G device shipments to be approximately 1.52 billion to 1.6 billion for calendar year 2015. At this time, we are not providing a forecast for calendar year 2015 reported 3G/4G device shipments. |
• | Our guidance for estimated fiscal fourth quarter and fiscal 2015 3G/4G total reported device sales includes an estimate of some prior period activity (i.e., devices shipped in prior periods) that may be reported to us. |
FOURTH FISCAL QUARTER | |||||||
Q4 FY14 Results | Current Guidance Q4 FY15 Estimates (1) | ||||||
Revenues | $6.7 | B | $4.7B - $5.7B | ||||
Year-over-year change | decrease 15% - 30% | ||||||
Non-GAAP diluted earnings per share (EPS) | $1.26 | $0.75 - $0.95 | |||||
Year-over-year change | decrease 25% - 40% | ||||||
Diluted EPS attributable to QSI | $0.02 | ($0.01 | ) | ||||
Diluted EPS attributable to share-based compensation | ($0.12 | ) | ($0.13 | ) | |||
Diluted EPS attributable to other items | ($0.05 | ) | ($0.05) - ($0.10) | ||||
GAAP diluted EPS | $1.11 | $0.51 - $0.76 | |||||
Year-over-year change | decrease 32% - 54% | ||||||
Metrics | |||||||
MSM chip shipments | 236 | M | 170M - 190M | ||||
Year-over-year change | decrease 19% - 28% | ||||||
Total reported device sales* (2) | approx. $57.4B | approx. $60.5B - $66.5B (3) | |||||
Year-over-year change | increase 5% - 16% | ||||||
*Est. sales in June quarter, reported in September quarter |
FISCAL YEAR | ||||||||||
FY 2014 Results | Prior Guidance FY 2015 Estimates | Current Guidance FY 2015 Estimates (1) | ||||||||
Revenues | $26.5 | B | $25.0B - $27.0B | $24.5B - $25.5B | ||||||
Year-over-year change | decrease 6% - increase 2% | decrease 4% - 8% | ||||||||
Non-GAAP diluted EPS | $5.27 | $4.60 - $5.00 | $4.50 - $4.70 | |||||||
Year-over-year change | decrease 5% - 13% | decrease 11% - 15% | ||||||||
Diluted EPS attributable to QSI | $0.01 | ($0.04 | ) | ($0.04 | ) | |||||
Diluted EPS attributable to share-based compensation | ($0.50 | ) | ($0.54 | ) | ($0.52 | ) | ||||
Diluted EPS attributable to other items | ($0.13 | ) | ($0.74 | ) | ($0.84) - ($0.89) | |||||
GAAP diluted EPS | $4.65 | $3.28 - $3.68 | $3.05 - $3.30 | |||||||
Year-over-year change | decrease 21% - 29% | decrease 29% - 34% | ||||||||
Metrics | ||||||||||
Total reported device sales* (2) | approx. $243.6B | approx. $255.0B - $275.0B (3) | approx. $253.0B - $259.0B (3) | |||||||
Year-over-year change | increase 5% - 13% | increase 4% - 6% | ||||||||
*Est. sales in Sept. to June quarters, reported in Dec. to Sept. quarters |
(1) | Our guidance range for GAAP for the fourth quarter of fiscal 2015 includes an estimate of restructuring and restructuring-related charges of $100 million to $200 million; these charges are excluded from our Non-GAAP guidance. |
(2) | Total reported device sales is the sum of all reported sales in U.S. dollars (as reported to us by our licensees) of all licensed CDMA-based, OFDMA-based and CDMA/OFDMA multimode subscriber devices (including handsets, modules, modem cards and other subscriber devices) by our licensees during a particular period (collectively, 3G/4G devices). The reported quarterly estimated ranges of average selling prices (ASPs) and unit shipments are determined based on the information as reported to us by our licensees during the relevant period and our own estimates of the selling prices and unit shipments for licensees that do not provide such information. Not all licensees report sales, selling prices and/or unit shipments the same way (e.g., some licensees report sales net of permitted deductions, including transportation, insurance, packing costs and other items, while other licensees report sales and then identify the amount of permitted deductions in their reports), and the way in which licensees report such information may change from time to time. In addition, certain licensees may not report (in the quarter in which they are contractually obligated to report) their sales of certain types of subscriber units, which (as a result of audits, legal actions or for other reasons) may be reported in a subsequent quarter. Accordingly, total reported device sales, estimated unit shipments and estimated ASPs for a particular period may include prior period activity that was not reported by the licensee until such particular period. |
(3) | Our guidance range for the fourth quarter of fiscal 2015 and fiscal 2015 total reported device sales reflects estimated 3G/4G total reported device sales that we currently expect to be reported to us, which includes an estimate of some prior period activity (i.e., devices shipped in prior periods) that may be reported to us. |
SEGMENTS | QCT | QTL | Non-GAAP Reconciling Items (a) | Non-GAAP | QSI | Share-Based Compensation | Other Items (b) (c) (d) | GAAP | |||||||||||||||
Q3 - FISCAL 2015 | |||||||||||||||||||||||
Revenues | $3,853 | $1,931 | $48 | $5,832 | $— | $— | $— | $5,832 | |||||||||||||||
Change from prior year | (22 | %) | 7 | % | 4 | % | (14 | %) | (14 | %) | |||||||||||||
Change from prior quarter | (13 | %) | (20 | %) | 4 | % | (15 | %) | (15 | %) | |||||||||||||
Cost of equipment and services revenues | $2,386 | $— | $10 | $55 | $2,451 | ||||||||||||||||||
Research and development | 1,226 | 2 | 176 | 3 | 1,407 | ||||||||||||||||||
Selling, general and administrative | 491 | 19 | 85 | (18) | 577 | ||||||||||||||||||
Other expenses | 20 | — | — | 142 | 162 | ||||||||||||||||||
Operating income (loss) | $1,709 | ($21) | ($271) | ($182) | $1,235 | ||||||||||||||||||
Change from prior year | (30 | %) | N/M | 1 | % | N/M | (40 | %) | |||||||||||||||
Change from prior quarter | (37 | %) | N/M | (9 | %) | 84 | % | (8 | %) | ||||||||||||||
Investment income, net | $191 | (e) | ($28) | (f) | $— | $— | $163 | ||||||||||||||||
EBT | $289 | $1,654 | ($43) | $1,900 | ($49) | ($271) | ($182) | $1,398 | |||||||||||||||
Change from prior year | (74 | %) | 7 | % | N/M | (33 | %) | N/M | 1 | % | N/M | (44 | %) | ||||||||||
Change from prior quarter | (61 | %) | (23 | %) | N/M | (35 | %) | (53 | %) | (9 | %) | 84 | % | (9 | %) | ||||||||
EBT as % of revenues | 8 | % | 86 | % | N/M | 33 | % | 24 | % | ||||||||||||||
Net income (loss) | $1,611 | ($26) | ($213) | ($188) | $1,184 | ||||||||||||||||||
Change from prior year | (35 | %) | N/M | 8 | % | N/M | (47 | %) | |||||||||||||||
Change from prior quarter | (31 | %) | 4 | % | (3 | %) | 82 | % | 12 | % | |||||||||||||
Diluted EPS | $0.99 | ($0.02) | ($0.13) | ($0.12) | $0.73 | ||||||||||||||||||
Change from prior year | (31 | %) | N/M | 7 | % | N/M | (44 | %) | |||||||||||||||
Change from prior quarter | (29 | %) | — | % | (8 | %) | 81 | % | 16 | % | |||||||||||||
Diluted shares used | 1,629 | 1,629 | 1,629 | 1,629 | 1,629 | ||||||||||||||||||
Q2 - FISCAL 2015 | |||||||||||||||||||||||
Revenues | $4,434 | $2,414 | $46 | $6,894 | $— | $— | $— | $6,894 | |||||||||||||||
Operating income (loss) | 2,707 | (4) | (249) | (1,118) | 1,336 | ||||||||||||||||||
EBT | $750 | $2,162 | $26 | 2,938 | (32) | (249) | (1,118) | 1,539 | |||||||||||||||
Net income (loss) | 2,339 | (27 | ) | (206) | (1,053) | 1,053 | |||||||||||||||||
Diluted EPS | $1.40 | ($0.02) | ($0.12) | ($0.63) | $0.63 | ||||||||||||||||||
Diluted shares used | 1,667 | 1,667 | 1,667 | 1,667 | 1,667 | ||||||||||||||||||
Q3 - FISCAL 2014 | |||||||||||||||||||||||
Revenues | $4,957 | $1,803 | $46 | $6,806 | $— | $— | $— | $6,806 | |||||||||||||||
Operating income (loss) | 2,425 | (5) | (274) | (71) | 2,075 | ||||||||||||||||||
EBT | $1,116 | $1,550 | $177 | 2,843 | (1) | (274) | (71) | 2,497 | |||||||||||||||
Net income (loss) | 2,470 | — | (232) | — | 2,238 | ||||||||||||||||||
Diluted EPS | $1.44 | $0.00 | ($0.14) | $0.00 | $1.31 | ||||||||||||||||||
Diluted shares used | 1,714 | 1,714 | 1,714 | 1,714 | 1,714 | ||||||||||||||||||
Q4 - FISCAL 2014 | |||||||||||||||||||||||
Revenues | $4,849 | $1,795 | $48 | $6,692 | $— | $— | $— | $6,692 | |||||||||||||||
Operating income (loss) | 2,323 | (3) | (252) | (76) | 1,992 | ||||||||||||||||||
EBT | $1,045 | $1,536 | ($30) | 2,551 | 29 | (252) | (76) | 2,252 | |||||||||||||||
Net income (loss) | 2,143 | 28 | (199) | (78) | 1,894 | ||||||||||||||||||
Diluted EPS | $1.26 | $0.02 | ($0.12) | ($0.05) | $1.11 | ||||||||||||||||||
Diluted shares used | 1,701 | 1,701 | 1,701 | 1,701 | 1,701 |
(a) | Non-GAAP reconciling items related to revenues consisted primarily of nonreportable segment revenues less intersegment eliminations. Non-GAAP reconciling items related to earnings before taxes consisted primarily of certain research and development expenses, selling, general and administrative expenses, other expenses or income and certain investment income that are not allocated to the segments for management reporting purposes; nonreportable segment results; and the elimination of intersegment profit. |
(b) | Beginning in the first quarter of fiscal 2015, we changed our methodology for reporting Non-GAAP results to exclude third-party acquisition and integration services costs and certain other items, which may include major restructuring and restructuring-related costs, goodwill and long-lived asset impairment charges and litigation settlements and/or damages. In the third quarter of fiscal 2015, other items excluded from Non-GAAP EBT included impairment charges of $131 million and $11 million related to goodwill and intangible assets, respectively, $78 million of acquisition-related items and $6 million of severance costs related to restructurings, partially offset by a $44 million gain on the sale of certain assets. |
(c) | In the third quarter of fiscal 2015, the tax expense in the “Other Items” column included a $4 million tax expense to reconcile the tax provision for each column to the total GAAP tax provision for the quarter, a $1 million tax expense for the tax effect of other items in EBT and a $1 million tax expense for the tax effect of acquisition-related items. At fiscal year end, the quarterly tax provision (benefit) for each column equals the annual tax provision (benefit) for each column computed in accordance with GAAP. In interim quarters, the sum of these provisions (benefits) may not equal the total GAAP tax provision, and this difference is included in the tax provision (benefit) in the “Other Items” column. In interim quarters of prior fiscal years, this difference was allocated to the tax provisions (benefits) among the columns. See the “Reconciliation of Non-GAAP Tax Rates to GAAP Tax Rates” herein. |
(d) | Details of amounts included in the “Other Items” column for prior periods are included in the releases for those periods. |
(e) | Included $127 million in interest and dividend income, $109 million in net realized gains on investments and $1 million in other net investment income, partially offset by $32 million in interest expense and $14 million in other-than-temporary losses on investments. |
(f) | Included $41 million in other-than-temporary losses on investments, partially offset by $13 million in other net investment income. |
SEGMENTS | QCT | QTL | Non-GAAP Reconciling Items (a) | Non-GAAP | QSI | Share-Based Compensation | Other Items (d) (g) (h) | GAAP | |||||||||||||||
9 MONTHS - FISCAL 2015 | |||||||||||||||||||||||
Revenues | $13,529 | $6,162 | $134 | $19,825 | $— | $— | $— | $19,825 | |||||||||||||||
Change from prior year | (2 | %) | 7 | % | (35 | %) | — | % | — | % | |||||||||||||
Cost of equipment and services revenues | $7,909 | $— | $33 | $184 | $8,126 | ||||||||||||||||||
Research and development | 3,582 | 5 | 508 | 38 | 4,133 | ||||||||||||||||||
Selling, general and administrative | 1,366 | 27 | 252 | 44 | 1,689 | ||||||||||||||||||
Other expenses | 20 | — | — | 1,221 | 1,241 | ||||||||||||||||||
Operating income (loss) | $6,948 | ($32) | ($793) | ($1,487) | $4,636 | ||||||||||||||||||
Change from prior year | 5 | % | (100 | %) | 2 | % | N/M | (17 | %) | ||||||||||||||
Investment income, net | $650 | (i) | ($50) | (j) | $— | $— | $600 | ||||||||||||||||
EBT | $2,185 | $5,395 | $18 | $7,598 | ($82) | ($793) | ($1,487) | $5,236 | |||||||||||||||
Change from prior year | (21 | %) | 7 | % | N/M | — | % | N/M | 2 | % | N/M | (20 | %) | ||||||||||
EBT as % of revenues | 16 | % | 88 | % | N/M | 38 | % | 26 | % | ||||||||||||||
Net income (loss) | $6,213 | ($53) | ($648) | ($1,303) | $4,209 | ||||||||||||||||||
Change from prior year | (10 | %) | N/M | 1 | % | N/M | (31 | %) | |||||||||||||||
Diluted EPS | $3.74 | ($0.03) | ($0.39) | ($0.78) | $2.53 | ||||||||||||||||||
Change from prior year | (7 | %) | N/M | (3 | %) | N/M | (28 | %) | |||||||||||||||
Diluted shares used | 1,661 | 1,661 | 1,661 | 1,661 | 1,661 | ||||||||||||||||||
9 MONTHS - FISCAL 2014 | |||||||||||||||||||||||
Revenues | $13,816 | $5,774 | $205 | $19,795 | $— | $— | $— | $19,795 | |||||||||||||||
Operating income (loss) | 6,611 | (16) | (806) | (231) | 5,558 | ||||||||||||||||||
EBT | $2,762 | $5,054 | ($217) | 7,599 | (36) | (806) | (231) | 6,526 | |||||||||||||||
Discontinued operations, net of tax | 430 | — | — | — | 430 | ||||||||||||||||||
Net income (loss) | 6,888 | (13) | (655) | (147) | 6,073 | ||||||||||||||||||
Diluted EPS | $4.01 | ($0.01) | ($0.38) | ($0.08) | $3.53 | ||||||||||||||||||
Diluted shares used | 1,718 | 1,718 | 1,718 | 1,718 | 1,718 | ||||||||||||||||||
12 MONTHS - FISCAL 2014 | |||||||||||||||||||||||
Revenues | $18,665 | $7,569 | $253 | $26,487 | $— | $— | $— | $26,487 | |||||||||||||||
Operating income (loss) | 8,933 | (18) | (1,059) | (306) | 7,550 | ||||||||||||||||||
EBT | $3,807 | $6,590 | ($247) | 10,150 | (7) | (1,059) | (306) | 8,778 | |||||||||||||||
Discontinued operations, net of tax | 430 | — | — | — | 430 | ||||||||||||||||||
Net income (loss) | 9,032 | 15 | (856) | (224) | 7,967 | ||||||||||||||||||
Diluted EPS | $5.27 | $0.01 | ($0.50) | ($0.13) | $4.65 | ||||||||||||||||||
Diluted shares used | 1,714 | 1,714 | 1,714 | 1,714 | 1,714 |
(g) | In the nine months ended June 28, 2015, other items excluded from Non-GAAP EBT included $975 million related to the resolution reached with the NDRC, $240 million of acquisition-related items, $235 million related to goodwill impairment charges, $43 million of severance costs related to restructurings and $38 million in impairment charges related to intangible assets, partially offset by a $44 million gain on the sale of certain assets. |
(h) | In the nine months ended June 28, 2015, the tax benefit in the “Other Items” column included a $101 million tax benefit related to fiscal 2014 as a result of the retroactive reinstatement of the federal R&D tax credit, a $61 million tax benefit as a result of an agreement reached with the Internal Revenue Service related to Atheros’ pre-acquisition tax returns, a $25 million tax benefit for the tax effect of other items in EBT and a $3 million tax benefit related to fiscal 2014 as a result of the retroactive reinstatement of other tax laws, partially offset by a $6 million tax expense to reconcile the tax provisions for each column to the total GAAP tax provision for the nine months ended June 28, 2015. See the “Reconciliation of Non-GAAP Tax Rates to GAAP Tax Rates” herein. |
(i) | Included $397 million in interest and dividend income, $371 million in net realized gains on investments and $6 million in other net investment income, partially offset by $90 million in other-than-temporary losses on investments and $34 million in interest expense. |
(j) | Included $71 million in other-than-temporary losses on investments and $18 million in equity in losses of investees, partially offset by $28 million in net realized gains on investments and $11 million in other net investment income. |
Three Months Ended June 28, 2015 | |||||||||||||||||||||||||
($ in millions) | Non-GAAP Results | QSI | Share-Based Compensation | Other Items | GAAP Results | ||||||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | 1,900 | $ | (49 | ) | $ | (271 | ) | $ | (182 | ) | $ | 1,398 | ||||||||||||
Income tax (expense) benefit | (289 | ) | 22 | 58 | (6 | ) | (215 | ) | |||||||||||||||||
Income (loss) from continuing operations | $ | 1,611 | $ | (27 | ) | $ | (213 | ) | $ | (188 | ) | $ | 1,183 | ||||||||||||
Tax rate | 15 | % | 45 | % | 21 | % | (3 | %) | 15 | % |
Nine Months Ended June 28, 2015 | |||||||||||||||||||||||||
($ in millions) | Non-GAAP Results | QSI | Share-Based Compensation | Other Items | GAAP Results | ||||||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | 7,598 | $ | (82 | ) | $ | (793 | ) | $ | (1,487 | ) | $ | 5,236 | ||||||||||||
Income tax (expense) benefit | (1,385 | ) | 27 | 145 | 184 | (1,029 | ) | ||||||||||||||||||
Income (loss) from continuing operations | $ | 6,213 | $ | (55 | ) | $ | (648 | ) | $ | (1,303 | ) | $ | 4,207 | ||||||||||||
Tax rate | 18 | % | 33 | % | 18 | % | 12 | % | 20 | % |
• | QSI is excluded because the Company expects to exit its strategic investments in the foreseeable future, and the effects of fluctuations in the value of such investments and realized gains or losses are viewed by management as unrelated to the Company’s operational performance. |
• | Share-based compensation expense primarily relates to restricted stock units. Non-cash share-based compensation is excluded because management views such expenses as unrelated to the operating activities of the Company’s ongoing core businesses. |
• | Certain other items are excluded because management views such expenses as unrelated to the operating activities of the Company’s ongoing core businesses, as follows: |
• | Acquisition-related items include amortization of certain intangible assets, recognition of the step-up of inventories to fair value and the related tax effects of these items starting with acquisitions completed in the third quarter of fiscal 2011, as well as any tax effects from restructuring the ownership of such acquired assets. Additionally, the Company excludes expenses related to the termination of contracts that limit the use of the acquired intellectual property. Starting in the first quarter of fiscal 2015, the Company excludes third-party |
• | Starting in the first quarter of fiscal 2015, the Company excludes certain other items that management views as unrelated to the Company’s ongoing business, such as major restructuring and restructuring-related costs, goodwill and long-lived asset impairments and litigation settlements and/or damages. Prior year amounts have not been reclassified to conform to the current presentation. |
• | Certain tax items that are unrelated to the fiscal year in which they are recorded are excluded in order to provide a clearer understanding of the Company’s ongoing Non-GAAP tax rate and after tax earnings. Also, the provision (benefit) to reconcile the tax provisions (benefits) for each column to the total GAAP tax provision for the quarter is excluded. At fiscal year end, the quarterly tax provision (benefit) for each column equals the annual tax provision (benefit) for each column computed in accordance with GAAP. In interim quarters, the sum of these provisions (benefits) may not equal the total GAAP tax provision, and this difference is included in the tax provision (benefit) in the “Other Items” column. In interim quarters of prior fiscal years, this difference was allocated to the tax provisions (benefits) among the columns. |
June 28, 2015 | September 28, 2014 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 9,987 | $ | 7,907 | |||
Marketable securities | 11,344 | 9,658 | |||||
Accounts receivable, net | 1,961 | 2,412 | |||||
Inventories | 1,583 | 1,458 | |||||
Deferred tax assets | 472 | 577 | |||||
Other current assets | 581 | 401 | |||||
Total current assets | 25,928 | 22,413 | |||||
Marketable securities | 13,894 | 14,457 | |||||
Deferred tax assets | 1,275 | 1,174 | |||||
Property, plant and equipment, net | 2,574 | 2,487 | |||||
Goodwill | 4,259 | 4,488 | |||||
Other intangible assets, net | 2,405 | 2,580 | |||||
Other assets | 1,960 | 975 | |||||
Total assets | $ | 52,295 | $ | 48,574 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Trade accounts payable | $ | 1,412 | $ | 2,183 | |||
Payroll and other benefits related liabilities | 697 | 802 | |||||
Unearned revenues | 680 | 785 | |||||
Short-term debt | 1,000 | — | |||||
Other current liabilities | 2,294 | 2,243 | |||||
Total current liabilities | 6,083 | 6,013 | |||||
Unearned revenues | 2,576 | 2,967 | |||||
Long-term debt | 9,913 | — | |||||
Other liabilities | 527 | 428 | |||||
Total liabilities | 19,099 | 9,408 | |||||
Stockholders’ equity: | |||||||
Qualcomm stockholders’ equity: | |||||||
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding | — | — | |||||
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,578 and 1,669 shares issued and outstanding, respectively | — | 7,736 | |||||
Retained earnings | 32,699 | 30,799 | |||||
Accumulated other comprehensive income | 503 | 634 | |||||
Total Qualcomm stockholders’ equity | 33,202 | 39,169 | |||||
Noncontrolling interests | (6 | ) | (3 | ) | |||
Total stockholders’ equity | 33,196 | 39,166 | |||||
Total liabilities and stockholders’ equity | $ | 52,295 | $ | 48,574 |
Three Months Ended | Nine Months Ended | ||||||||||||||
June 28, 2015 | June 29, 2014 | June 28, 2015 | June 29, 2014 | ||||||||||||
Revenues: | |||||||||||||||
Equipment and services | $ | 3,840 | $ | 4,922 | $ | 13,459 | $ | 13,803 | |||||||
Licensing | 1,992 | 1,884 | 6,366 | 5,992 | |||||||||||
Total revenues | 5,832 | 6,806 | 19,825 | 19,795 | |||||||||||
Costs and expenses: | |||||||||||||||
Cost of equipment and services revenues | 2,451 | 2,740 | 8,126 | 7,929 | |||||||||||
Research and development | 1,407 | 1,429 | 4,133 | 4,113 | |||||||||||
Selling, general and administrative | 577 | 582 | 1,689 | 1,745 | |||||||||||
Other | 162 | (20 | ) | 1,241 | 450 | ||||||||||
Total costs and expenses | 4,597 | 4,731 | 15,189 | 14,237 | |||||||||||
Operating income | 1,235 | 2,075 | 4,636 | 5,558 | |||||||||||
Investment income, net | 163 | 422 | 600 | 968 | |||||||||||
Income from continuing operations before income taxes | 1,398 | 2,497 | 5,236 | 6,526 | |||||||||||
Income tax expense | (215 | ) | (260 | ) | (1,029 | ) | (886 | ) | |||||||
Income from continuing operations | 1,183 | 2,237 | 4,207 | 5,640 | |||||||||||
Discontinued operations, net of income taxes | — | — | — | 430 | |||||||||||
Net income | 1,183 | 2,237 | 4,207 | 6,070 | |||||||||||
Net loss attributable to noncontrolling interests | 1 | 1 | 2 | 3 | |||||||||||
Net income attributable to Qualcomm | $ | 1,184 | $ | 2,238 | $ | 4,209 | $ | 6,073 | |||||||
Basic earnings per share attributable to Qualcomm: | |||||||||||||||
Continuing operations | $ | 0.74 | $ | 1.33 | $ | 2.57 | $ | 3.35 | |||||||
Discontinued operations | — | — | — | 0.25 | |||||||||||
Net income | $ | 0.74 | $ | 1.33 | $ | 2.57 | $ | 3.60 | |||||||
Diluted earnings per share attributable to Qualcomm: | |||||||||||||||
Continuing operations | $ | 0.73 | $ | 1.31 | $ | 2.53 | $ | 3.28 | |||||||
Discontinued operations | — | — | — | 0.25 | |||||||||||
Net income | $ | 0.73 | $ | 1.31 | $ | 2.53 | $ | 3.53 | |||||||
Shares used in per share calculations: | |||||||||||||||
Basic | 1,608 | 1,683 | 1,638 | 1,686 | |||||||||||
Diluted | 1,629 | 1,714 | 1,661 | 1,718 | |||||||||||
Dividends per share announced | $ | 0.48 | $ | 0.42 | $ | 1.32 | $ | 1.12 |
Three Months Ended | Nine Months Ended | ||||||||||||||
June 28, 2015 | June 29, 2014 | June 28, 2015 | June 29, 2014 | ||||||||||||
Operating Activities: | |||||||||||||||
Net income | $ | 1,183 | $ | 2,237 | $ | 4,207 | $ | 6,070 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
Depreciation and amortization expense | 297 | 292 | 888 | 853 | |||||||||||
Gain on sale of discontinued operations | — | — | — | (665 | ) | ||||||||||
Long-lived asset and goodwill impairment charges | 166 | 164 | 304 | 642 | |||||||||||
Income tax provision in excess of (less than) income tax payments | 86 | (24 | ) | 159 | 244 | ||||||||||
Non-cash portion of share-based compensation expense | 271 | 274 | 793 | 806 | |||||||||||
Incremental tax benefits from share-based compensation | (20 | ) | (70 | ) | (98 | ) | (239 | ) | |||||||
Net realized gains on marketable securities and other investments | (122 | ) | (298 | ) | (399 | ) | (685 | ) | |||||||
Impairment losses on marketable securities and other investments | 55 | 11 | 161 | 170 | |||||||||||
Other items, net | 2 | 15 | (29 | ) | (5 | ) | |||||||||
Changes in assets and liabilities: | |||||||||||||||
Accounts receivable, net | 100 | 139 | 438 | 43 | |||||||||||
Inventories | 281 | (37 | ) | (122 | ) | 116 | |||||||||
Other assets | 241 | 9 | (897 | ) | 136 | ||||||||||
Trade accounts payable | (261 | ) | 286 | (769 | ) | 321 | |||||||||
Payroll, benefits and other liabilities | (1 | ) | (235 | ) | (406 | ) | (337 | ) | |||||||
Unearned revenues | (162 | ) | (90 | ) | (408 | ) | (202 | ) | |||||||
Net cash provided by operating activities | 2,116 | 2,673 | 3,822 | 7,268 | |||||||||||
Investing Activities: | |||||||||||||||
Capital expenditures | (366 | ) | (158 | ) | (815 | ) | (955 | ) | |||||||
Purchases of available-for-sale securities | (4,360 | ) | (2,488 | ) | (13,118 | ) | (10,315 | ) | |||||||
Proceeds from sales and maturities of available-for-sale securities | 3,266 | 4,060 | 11,897 | 9,744 | |||||||||||
Purchases of trading securities | (339 | ) | (1,054 | ) | (1,034 | ) | (2,868 | ) | |||||||
Proceeds from sales and maturities of trading securities | 298 | 826 | 1,008 | 2,619 | |||||||||||
Purchases of other marketable securities | — | (220 | ) | — | (220 | ) | |||||||||
Proceeds from sale of discontinued operations, net of cash sold | — | — | — | 788 | |||||||||||
Proceeds from sales of property, plant and equipment | 128 | 36 | 161 | 37 | |||||||||||
Acquisitions and other investments, net of cash acquired | (130 | ) | (100 | ) | (308 | ) | (447 | ) | |||||||
Other items, net | (27 | ) | 4 | (11 | ) | 65 | |||||||||
Net cash (used) provided by investing activities | (1,530 | ) | 906 | (2,220 | ) | (1,552 | ) | ||||||||
Financing Activities: | |||||||||||||||
Proceeds from short-term debt | 1,718 | — | 2,813 | — | |||||||||||
Proceeds from long-term debt | 9,937 | — | 9,937 | — | |||||||||||
Repayment of short-term debt | (1,813 | ) | — | (1,814 | ) | — | |||||||||
Proceeds from issuance of common stock | 154 | 194 | 571 | 1,147 | |||||||||||
Repurchases and retirements of common stock | (5,405 | ) | (1,350 | ) | (9,016 | ) | (3,354 | ) | |||||||
Dividends paid | (757 | ) | (706 | ) | (2,142 | ) | (1,884 | ) | |||||||
Incremental tax benefits from share-based compensation | 20 | 70 | 98 | 239 | |||||||||||
Other items, net | 50 | (184 | ) | 41 | (65 | ) | |||||||||
Net cash provided (used) by financing activities | 3,904 | (1,976 | ) | 488 | (3,917 | ) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | 5 | 4 | (10 | ) | 3 | ||||||||||
Net increase in cash and cash equivalents | 4,495 | 1,607 | 2,080 | 1,802 | |||||||||||
Cash and cash equivalents at beginning of period | 5,492 | 6,337 | 7,907 | 6,142 | |||||||||||
Cash and cash equivalents at end of period | $ | 9,987 | $ | 7,944 | $ | 9,987 | $ | 7,944 |